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Abstract
Background . Obesity is often associated with increased biliary cholesterol secretion resulting in cholesterol gallstone
formation. We have previously demonstrated that leptin-deficient C57Bl/6J Lep ob obese mice have abnormal biliary
motility and are prone to cholesterol crystal formation. In addition, others have demonstrated that leptin-deficient mice
when fed a lithogenic diet for eight weeks are not prone to gallstone formation. However, the biliary lipid and in vivo
cholesterol crystal response of homozygous and heterozygous leptin-deficient mice to four weeks on a lithogenic diet has not
been studied. Therefore, we tested the hypothesis that lithogenic diets influence gallbladder bile composition, serum lipids
and cholesterol crystal formation in homozygous and heterozygous leptin-deficient mice compared to normal lean controls.
Methods . 319 female lean control mice, 280 heterozygous lep ob obese mice and 117 homozygous lep ob obese mice were
studied. Mice were fed either a lithogenic or control non-lithogenic chow diet for four weeks. Gallbladder volumes were
measured, and bile was pooled to calculate cholesterol saturation indices. Serum cholesterol, glucose, and leptin levels were
determined. Hepatic fat vacuoles were counted, and bile was observed microscopically for cholesterol crystal formation.
Results . The lithogenic diet and mouse strain influenced body and liver weights, gallbladder volume, cholesterol crystal
formation, serum cholesterol, glucose and leptin levels and hepatic fat vacuole numbers. However, only diet, not strain,
altered biliary cholesterol saturation. Conclusion . The association among obesity, leptin, and gallstone formation may be
primarily related to altered gallbladder motility and cholesterol crystal formation and only secondarily to biliary cholesterol
saturation.
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Introduction
Cholesterol gallstone disease is the most widespread
digestive disorder in Western countries. In the United
States, approximately 12% of the adult population
have gallstones, and the cost of caring for these
patients is between 8 and 10 billion dollars annually
[1,2]. Cholesterol gallstones are a multifactorial dis-
ease involving a complex interaction between both
environmental and genetic factors including age, race,
gender, parity, diet, diabetes, family history, and
obesity. The formation of cholesterol gallstones re-
quires three pathophysiological conditions including
increased biliary secretion of cholesterol producing
cholesterol supersaturated bile, nucleation and growth
of cholesterol monohydrate crystals, and altered
biliary motility.
Obesity, which is also a polygenic and multifactorial
disease, has been well documented as a risk factor for
gallstone formation especially in women [3]. Obese
individuals have been shown to have supersaturated
bile (4,5), larger gallbladder fasting volumes [6], and
impaired gallbladder emptying [7]. Leptin, the pro-
tein product of the ob gene, is a small peptide
hormone produced primarily by adipose tissue and
is highly correlated with total body mass [8].
Recessive mutations in the mouse obese (ob)
and diabetes (db) genes result in weight gain
and diabetes conditions similar to human obesity.
Leptindeficient (ob/ob) and leptin-receptor deficient
(db/db) mice have similar phenotypes, weighing 2.5-3
times more than normal mice and have five times the
body fat content. In addition to obesity, ob/ob mice
exhibit hyperphagia, hyperglycemia, abnormal repro-
ductive functions, hormonal imbalances and de-
creased immune function. These mice are also
hypometabolic and hypothermic.
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We have recently reported that leptin-deficient
mice have increased resting gallbladder volume, an
indication of gallbladder stasis [9] and shortened
cholesterol crystal observation time, suggesting the
presence of increased cholesterol crystal pronuclea-
tors [10,11]. In addition, we have shown that leptin-
deficient mice have decreased gallbladder smooth
muscle response to excitatory stimuli such as,
acetylcholine, neuropeptide Y and cholecystokinin
[9], and that leptin administration ameliorates this
response [12]. Thus, these data suggest that de-
creased gallbladder motility and enhanced crystal
formation may play a role in gallstone pathogenesis
associated with obesity. Thus, the aim of this study
was to determine if genetically obese, leptin-defi-
cient mice have altered biliary lipids and enhanced
biliary cholesterol crystal formation in response to a
lithogenic diet.
Materials and Methods
Animals and Diet
Female C57Bl/6J lean control female mice (n/
319), C57Bl/6Jlepob heterozygous mice (n/280)
and C57Bl/6Jlepob homozygous mice (n/117)
were obtained from The Jackson Laboratory (Bar
Harbor, ME). The mice, aged 78 weeks, were
housed 45 per cage in a light (06001800) and
temperature (228 C) controlled room. Mice from
each strain were randomly divided into two groups
and given free access to either a control
non-lithogenic chow diet (contains trace amounts
of cholesterol) or a semi-synthetic lithogenic diet
containing 1% cholesterol and 0.5% cholic acid
(Dyets Inc., Bethlehem, PA) for four weeks. The
Medical College of Wisconsin Animal Care and Use
Committee approved the experiments described
herein.
Tissue Procurement
At 12 weeks of age the mice were deprived of food
overnight. The next morning the mice were anesthe-
tized with ketamine-xylazine (15 mg/Kg xyl, 50 mg/
Kg ket., IP) and then underwent a laparotomy,
cholecystectomy and hepatectomy. The liver weights
were measured, and a portion of the right lobe of the
liver was fixed in Bouin’s solution for histology. Bile
was aspirated from the gallbladders, and the volumes
were determined. An aliquot of bile was immediately
removed and observed for cholesterol crystal deter-
mination. Whole blood was aspirated from the heart
and centrifuged to isolate serum. Serum and bile were
pooled on the basis of known average fluid volumes to
obtain sufficient amounts for analyses as described
below.
Biliary Lipid Analysis
Pooled gallbladder bile samples were analyzed for
total bile acids, phospholipids, and cholesterol, as
previously described [13] and cholesterol saturation
indices were determined by Carey’s critical tables
[14].
Cholesterol Crystal Counts
Immediately following collection, 5 mL of gallbladder
bile were examined microscopically for the presence
of cholesterol crystals. Cholesterol crystals were
identified by their characteristic shape and by bire-
fringence using polarized light microscopy [15]. Ten
high power fields (400/) were examined, and the
mean number of crystals per high power field are
reported.
Serum Analysis
Serum total cholesterol, HDL cholesterol and glucose
were determined using commercially available diag-
nostic kits as per the manufacturer’s instructions
(Sigma Procedure Nos. 352, 352-7 and 635, respec-
tively, Sigma Chemical Co., St. Louis, MO). Serum
leptin levels were determined using a commercially
available radioimmunoassay (Linco Research, Inc.,
St. Charles, MO).
Fat Vacuoles
As a measure of hepatic steatosis, liver fat vacuoles
were identified and counted in hematoxylin and eosin
stained paraffin sections. Ten high power fields
(400/) were examined, and the mean number of
vacuoles per high power field are reported.
Statistical Analysis
Data are expressed as means9/SEM. Statistical differ-
ences were determined by two-way ANOVA, followed
by pairwise comparisons utilizing Mann-Whitney test
using SigmaStat Statistical Software version 2.03
(SPSS Inc., Chicago, IL). pB/0.05 was employed as
the nominal criterion of statistical significance.
Results
Strain and Diet Influence Body and Liver Weight. As
expected, regardless of the experimental diet, signifi-
cant differences in final mean body and liver weights
were observed among the strains at the time of surgery
(Table 1). Homozygous leptin-deficient mice had
significantly greater (pB/0.001) mean body and liver
weights than either the heterozygous or lean control
mice, with the heterozygotes being intermediate. Not
surprisingly, significant differences (pB/0.05) were
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observed in mean body and liver weights between
dietary treatments.
Strain and Diet Influence Gallbladder Volumes. Mean
gallbladder volumes were significantly greater (pB/
0.001) in homozygous leptin-deficient mice compared
to either the heterozygous leptin-deficient or lean
control mice regardless of experimental diet (Table 1,
Figure 1). Feeding lean control and homozygous
leptin-deficient mice a lithogenic diet for four weeks
significantly increased (pB/0.05) their gallbladder
volumes compared to mice given the control non-
lithogenic chow diet. However, heterozygous leptin-
deficient mice did not exhibit increased gallbladder
volumes.
Diet but not Strain Alters Biliary Lipids. Interestingly,
two-way ANOVA indicated that strain had no effect
on biliary lipids; but as expected, diet did significantly
(pB/0.05) alter biliary lipids (Table 2). When fed a
lithogenic diet, homozygous leptin-deficient obese
mice had decreased molar percent total bile acids
and increased molar percent phospholipids, but molar
percent cholesterol and CSI were not different from
lean control or heterozygous leptin-deficient mice.
However, two-way ANOVA did indicate significant
interactions between strain and diet for total bile
acids, phospholipids, cholesterol and total lipids, but
not for CSI.
Strain and Diet Influence Cholesterol Crystals. When fed
a lithogenic diet, homozygous leptin-deficient mice
had significantly greater (pB/0.001) number of biliary
cholesterol crystals than the lean controls (Figure 2).
Heterozygous leptin deficient mice had intermediate
number of crystals. No crystals were detected in any
strains when fed a control non-lithogenic diet.
Strain and Diet Influence Hepatic Fat Vacuoles. The
number of hepatic fat vacuoles per high power field
was determined as an indicator of hepatic fat storage.
Regardless of dietary treatment, the number of fat
vacuoles was significantly greater (pB/0.001) in the
homozygous leptin-deficient mice compared either
the heterozygous or lean control mice (Figure 3). As
expected, the number of vacuoles significantly in-
creased (pB/0.05) in all strains upon feeding a
lithogenic, high cholesterol diet compared to the
control non-lithogenic chow diet.
Strain and Diet Alter Serum Cholesterol, HDL
Cholesterol, Glucose and Leptin. As expected, serum
cholesterol was significantly higher (pB/0.001) in
homozygous leptin-deficient mice compared to either
the heterozygous or lean control mice, regardless of
the experimental diet (Table 3). Feeding a lithogenic,
high cholesterol diet significantly increased (pB/0.05)
serum cholesterol in all strains compared to the
Table 1. Comparison of Body Weight, Liver Weight, and Gallbladder Volume.
n Diet Body Wt. Liver Wt. GBV
Lean 191 chow 18.39/0.1a 0.99/0.01a 14.29/0.5a
Het-Ob 160 chow 20.89/0.1b 1.09/0.01b 17.69/0.5b
Homo-Ob 68 chow 49.99/0.4c 2.99/0.1c 34.79/2.2c
Lean 128 xol 18.39/0.1d 1.29/0.01*d 19.89/0.8*d
Het-Ob 120 xol 21.59/0.2*e 1.49/0.02*e 18.79/0.6d
Homo-Ob 49 xol 45.99/0.7*f 3.39/0.09*f 59.29/3.0*e
Two-Way ANOVA p-value
Strain Effects B/0.001 B/0.001 B/0.001
Diet Effects B/0.001 B/0.001 B/0.001
Strain-Diet Interaction B/0.001 0.128 B/0.001
NOTE: Data represent mean9/SEM.
Different superscript letters among strains on same diet indicate significant difference from one another, pB/0.001. * pB/0.05 vs same strain
on chow diet.
Abbreviations: Wt./weight, GBV/gallbladder volume.
Figure 1. Lithogenic diet (XOL) increases gallbladder volume in
lean and to a greater extent obese mice. Different letters above error
bars indicate means are significantly different from one another,
pB/0.001. *pB/0.05 vs. same strain on chow diet.
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control chow diet. Similar results were obtained for
serum HDL cholesterol. Serum glucose levels were
significantly higher (pB/0.001) and serum leptin
levels were significantly lower (pB/0.001) in homo-
zygous leptin-deficient mice compared to either the
heterozygous or lean control mice with both
diets. The high cholesterol diet significantly increased
(pB/0.05) serum leptin levels only in the lean control
but not in the leptin-deficient mice.
Discussion
Although clinical studies have suggested that obesity
is an important risk factor for gallstone disease, little is
known regarding the exact role that obesity plays in
the pathogenesis of this disease. Obesity has been
associated with excessive hepatic secretion of choles-
terol, larger gallbladder fasting volumes and impaired
gallbladder emptying [47]. We have previously
demonstrated that homozygous leptin-deficient Lep
ob mice have increased resting gallbladder volumes,
diminished in vitro response to neurotransmitters and
shorter crystal observation time compared to lean
controls when fed a non-lithogenic diet [911]. The
present study addresses the hypothesis that a litho-
genic diet will alter biliary and serum lipids and
increase the number of biliary cholesterol crystals in
heterozygous and homozygous leptin-deficient Lep ob
compared to lean controls. We have shown that a
lithogenic diet and mouse strain influence body and
liver weights, gallbladder volume, cholesterol crystal
formation, serum cholesterol, glucose and leptin
levels and hepatic fat vacuole numbers. However,
only diet altered the cholesterol saturation index
suggesting that gallstone formation in leptin-deficient
obesity may be due to altered biliary motility and
crystal formation.
Impaired gallbladder emptying has been implicated
in the pathogenesis of gallstones. In this and previous
studies from our laboratory, leptin-deficient Lep ob
mice had very large gallbladder volumes which
became even larger when fed a high cholesterol
lithogenic diet, while heterozygous leptin-deficient
lean mice have more normal gallbladder volumes
[9,16]. These data are consistent with those reported
by Bouchard et al. [17] in which female Lep ob mice,
fed the same lithogenic diet for eight weeks, had larger
gallbladder volumes compared to controls. However,
human studies examining ultrasound measurements
of gallbladder volume and emptying in obese patients
have been conflicting. In most reports larger resting
gallbladder volumes have been reported in obese
patients; however, this observation may be propor-
tional to body size and fat mass [6,7]. While some
human studies report that obesity is associated with
decreased gallbladder emptying [18], many studies
report normal emptying but an increased residual
volume due to the increased resting volume [19,20].T
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We have previously reported that homozygous
leptin-deficient Lep ob and leptin-resistant Lep db
obese mice have impaired in vitro gallbladder muscle
responses to acetylcholine, neuropeptide Y and cho-
lecystokinin compared to lean controls, while hetero-
zygous leptin-deficient lean mice had intermediate
responses [9,16,21]. In addition, agouti yellow Ay
obese mice, which have a defect in melanocortin 4
receptor function and normal leptin metabolism, have
a normal gallbladder response to biliary neurotrans-
mitters similar to lean controls [21]. Our findings
demonstrate that leptin dysfunction plays an integral
role in obesity-associated biliary stasis. Surprisingly,
this ‘‘dose-response’’ effect did not apply to our
observations with respect to biliary lipids.
In addition to biliary stasis, human obesity has also
been associated with altered cholesterol metabolism
including excess secretion of cholesterol into bile
[4,5]. In our murine model of obesity, homozygous
and heterozygous leptin-deficient Lep ob mice fed a
lithogenic diet for four weeks increased biliary cho-
lesterol and CSI levels regardless of the mouse strain.
In contrast, Bouchard et al. [17] reported that female
Lep ob mice fed the same lithogenic diet for 8 weeks,
had decreased biliary cholesterol and CSI levels
compared to C57Bl/6J controls. This difference may
reflect the longer feeding times with gallstone forma-
tion in the study by Bouchard and associates [17].
However, with respect to biliary lipid analysis the
present study has the advantage that 814 bile pools
were measured so that statistical analyses could be
preformed. In the study by Bouchard et al. [17] only
one bile pool was available in each group.
Currently, no data are available on biliary lipids in
leptin-deficient humans. In fact, spontaneous muta-
tions in leptin are rarely a cause of human obesity, and
most obese humans are leptin-resistant. Therefore, we
have also investigated leptin-resistant obese mice (Lep
db) which more closely parallel human obesity. We
have recently reported that Lep db mice have low
biliary cholesterol levels and CSI compared to lean
controls [22] as well as a diminished tendency to form
cholesterol crystals when fed a high cholesterol diet.
However, Lep db, like Lep ob, mice have increased
gallbladder volumes and a diminished in vitro re-
sponse to neurotransmitters, supporting a role for
biliary stasis in leptin-resistant obesity-associated
gallstone pathogenesis.
In contrast to the leptin-resistant mice, in this study
of leptin-deficient mice, cholesterol saturation indices
increased in all strains when fed a lithogenic diet.
Thus, biliary cholesterol crystals also significantly
increased in all strains when fed a lithogenic diet.
However, homozygous leptin-deficient mice had sig-
nificantly greater number of biliary cholesterol crys-
tals than the lean controls, while heterozygous leptin-
deficient mice had an intermediate number of crys-
tals, suggesting that cholesterol crystal formation is
strain dependent. These data are consistent with our
previous findings that crystal observation time (COT)
is shortened in Lep ob mice compared to controls
(7.09/0.4 vs 10.29/0.6 days), and that crystal growth
and crystal mass are both increased [10]. However, in
contrast, Hyogo et al. [23] reported no crystal
formation in male ob mice fed a similar lithogenic
diet for 4 weeks. In addition, we have also identified
carboxylesterase as a cholesterol crystal pronucleator
in the bile of Lep ob mice [11,24]. Thus, leptin-
deficient mice have both altered gallbladder motility
and enhanced cholesterol crystal formation.
Hepatic metabolism of fatty acids is disrupted in
leptin-deficient obese mice leading to steatosis and
hepatic insulin resistance [25]. As expected, obese
leptin-deficient mice had increased number of hepatic
Figure 2. Lithogenic diet (XOL) increases the number of biliary
cholesterol crystals/10 high-powered fields (hpf) (400/) in lean
and to a greater extent, obese mice. The number of cholesterol
crystals represents the total of 10 high-powered fields evaluated.
Different letters above error bars indicate means are significantly
different from one another, pB/0.001. *pB/0.05 vs. same strain on
chow diet.
Figure 3. Lithogenic diet (XOL) increases hepatic steatosis in lean
and to a greater extent, obese mice. The number of hepatic fat
vacuoles represents the mean of 10 high-powered field (hpf) (400x)
evaluated. Different letters above error bars indicate means are
significantly different from one another, pB/0.001. *pB/0.05 vs.
same strain on chow diet.
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fat vacuoles compared to controls, consistent with
their obesity. The number of fat vacuoles was en-
hanced when fed a lithogenic diet in all strains but to a
greater degree in the leptin-deficient mice. Diehl [26]
has suggested that leptin deficiency alters the liver’s
immune system and thereby increases its sensitivity to
TNF-a which can inhibit insulin signal transduction.
Interestingly, the heterozygotes had similar numbers
of fat vacuoles compared to lean controls, which to
our knowledge has not been previously reported. In
humans, obesity-associated steatosis may also be
associated with nonalcoholic steatohepatitis
(NASH), characterized by, not only hepatic steatosis,
but also fibrosis and inflammation. However, pub-
lished reports examining the association between
serum leptin and hepatic steatosis have yielded con-
flicting results. In two of these studies, Uygun et al.
[27] and Chitturi et al. [28] reported that serum
leptin levels were significantly higher in patients with
NASH compared with controls. In contrast, Chala-
sani et al. [29] found no differences in hepatic leptin
mRNA, leptin receptor mRNA or serum leptin levels
between patients with NASH and controls. Therefore,
while NASH is believed to be a major contributor to
the overall morbidity and mortality of obesity a direct
role of leptin in the pathogenesis of human NASH has
yet to be established.
In addition to abnormal fatty acid metabolism,
leptin-deficient mice have altered glucose and lipo-
protein metabolism leading to hyperglycemia and
hypercholesterolemia. In the current study the litho-
genic diet increased serum cholesterol and HDL
levels in both the homozygous and heterozygous
leptin-deficient mice compared to controls. In addi-
tion, serum glucose increased with the lithogenic diet
in the heterozygous mice and was significantly ele-
vated in the homozygous leptin-deficient mice regard-
less of diet. We have recently reported a negative
correlation between serum glucose, insulin, choles-
terol, and triglyceride levels as well as body weight
with gallbladder contractility [16]. Moreover, we have
also shown that gallbladder myocytes from both
leptin-deficient and leptin-resistant mice are forshor-
tened and have diminished response to cholecystoki-
nin [30]. Thus, hyperglycemia, insulin-resistance and
hyperlipidemia in obese mice are associated with
impaired gallbladder contractility which may contri-
bute to obesity-associated gallstone pathogenesis.
In summary, lithogenic diet and mouse strain
influenced body and liver weights, gallbladder vo-
lume, cholesterol crystal formation, serum choles-
terol, glucose and leptin levels as well as the number
of hepatic fat vacuoles. However, only diet, but not
strain, altered biliary cholesterol saturation. There-
fore, these data and our studies of gallbladder motility
and cholesterol crystallization suggest that the asso-
ciation between obesity and gallstone formation may
not require increased cholesterol saturation. However,
the increased incidence of gallstones observed in
obesity may result from altered gallbladder emptying
and enhanced crystal formation in patients who
already have cholesterol supersaturated bile.
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